Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04631718 · ClinicalTrials.gov registry record
MRI QSM Imaging for Iron Overload
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 63
- Enrollment target
NCT04631718 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 63 participants.
The verdict
NCT04631718 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
The overall goal of this project is to develop and validate a novel technique for Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM) of the abdomen, for non-invasive assessment of liver iron deposition. In this work, study team will develop and optimize advanced data acquisition and image reconstruction methods to enable QSM of the abdomen. Further, investigators will determine the accuracy, repeatability, and reproducibility of abdominal QSM for iron quantification in patients with liver iron overload. Excessive accumulation of iron in various organs, including the liver, which affects both adult and pediatric populations, is toxic and requires treatment aimed at reducing body iron stores. Accurate assessment of liver iron concentration is critical for the detection and staging of iron overload as well as for longitudinal monitoring during treatment. In summary, this project will develop a novel MRI-based QSM technique designed for the abdomen and will validate it in pediatric and adult patients with liver iron overload. Upon successful validation, QSM will provide accurate, repeatable, and reproducible quantification of LIC based on a fundamental property of tissue.
Interventions
- RADIATION Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2024-04-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04631718
The ClinicalTrials.gov registry entry for NCT04631718 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM) is the first listed.
NCT04631718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04631718 about?
NCT04631718 is a clinical study titled "MRI QSM Imaging for Iron Overload". The overall goal of this project is to develop and validate a novel technique for Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM) of the abdomen, for non-invasive assessment of liver iron deposition. In this work, study team will develop and optimize advanced data ac...
What is the current status of trial NCT04631718?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2022-01-18. Estimated completion is 2024-04-29.
What interventions are being tested in trial NCT04631718?
The interventions under investigation include: Magnetic Resonance Imaging (MRI)-based Quantitative Susceptibility Mapping (QSM) (RADIATION).
Who is sponsoring clinical trial NCT04631718?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.